Clinical trial
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of PRV-015 in Adult Patients With Non-Responsive Celiac Disease as an Adjunct to a Gluten-free Diet
NCT04424927 is registered in ClinicalTrials.gov with Provention Bio, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of PRV-015 in Adult Patients With Non-Responsive Celiac Disease as an Adjunct to a Gluten-free Diet
- Lead sponsor
- Provention Bio, a Sanofi Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 24, 2020
- Completion date
- July 30, 2024
- Enrollment
- 388 (actual)
- Sites
- 38
Conditions
As the registry lists them; a condition with its own page is linked.